Stock Analysis: Extendicare
Image Source: Pexels
Incorporated in 1968 and is based in Markham, Canada, Extendicare (EXETF) is a senior care provider in Canada, focused on long-term care and home health care.
The company has three main business segments namely Long-term Care (LTC), Home Health Care, and Managed Services.
Three key data points gauge Extendicare or any dividend paying entity, namely:
(1) Price
(2) Dividends
(3) Returns
Those keys also show if any company has made, is making, and will make money.
EXETF Price
Extendicare’s price grew just over 79% last year from $5.75 to $10.30 as of Thursday’s closing price.
EXETF Dividends
Extendicare has paid variable monthly dividends since October, 2010.
The current forward looking annual dividend of $0.37 yields 3.61% per Wednesday’s $10.30 closing price.
EXETF Returns
Putting it all together, a $1.57 estimated gross gain per share shows up when adding EXETF’s annual $0.37 dividend to an estimated $1.20 analyst estimated annual price gain, totaling that $1.57 gross gain.
A little under $1000 invested at the recent $10.30 price would buy 97 shares which, multiplies the estimated $1.57 gross gain to $152.29.
Furthermore almost 25% of that $152.00 gain comes from the $36.10 in dividends generated from a $1,000 investment, and the $36.10 amounts to over 3.5 times the recent $10.30 single-share price.
(A dividend dogcatcher rule is to never buy a dividend from $1000 invested that pays less than the cost of a single share.)
Therefore, you may choose to pounce on Extendicare and its 3.61% dividend yield along with its 15 year dividend record.
The exact track of EXETF’s future prices and dividends will entirely be determined by market action and company finances.
Remember the best way to track stock performance and dividend payments is through direct ownership of company shares.
More By This Author:
Stock Analysis: Spok Holdings
Stock Analysis - Sienna Senior Living
Stock Analysis: Chemical Works Of Gedeon Richter
Disclaimer: This article is for informational and educational purposes only and should not be construed to constitute investment advice. Nothing contained herein shall constitute a solicitation, ...
more